to-BBB's Series B Round

to-BBB raised a round of funding on February 03, 2011.

to-BBB is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs w…

Articles about to-BBB's Series B Round: